Robert Lanza featured on

Stem Cell

Stem-cell science is a fast-moving field. Just three years since a Japanese researcher first reprogrammed ordinary skin cells into stem cells without the use of embryos, scientists at a Massachusetts biotech company have repeated the feat, only this time with a new method that creates the first stem cells safe enough for human use. The achievement brings the potentially

Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology (ACT), reported today in the journal Cell that his team has created stem cells using human skin cells and four proteins. The innovation builds on the breakthrough discovery in 2006 by Shinya Yamanaka, who similarly coaxed human skin cells to revert to a pristine, embryonic state by introducing four key genes into the cells, piggybacked on viruses. However, some of those genes are known to cause cancer, which made Yamanaka’s stem cells — known as induced pluripotent stem cells, or iPS cells — unsuitable for human use. ( )

Still, the rapid pace of the research means we may not have to wait long. “We really lucked out,” says Lanza. “These iPS cells were just discovered a few years ago, and here we are three years later with a method safe enough to actually use in people.” ACT plans to file a request for the first human trial using its cells sometime next year. The findings may herald a practical solution to the problem of embryonic stem cells, the controversial cells that can be derived only from embryos (researchers currently use embryos that have been discarded during fertility treatments). President Obama recently lifted the long-standing ban on federal funding of human-embryonic-stem-cell research, but still, these stem cells are unlikely to prove useful as human treatments — for maladies like diabetes, Parkinson’s or spinal-cord injuries — since they would not be tissue-matched to the individual patients who need them. The new method could allow scientists to create stem cells using a patient’s own skin cells, eliminating the possibility of rejection.

While the new iPS cells may be safer, even Lanza admits there is much that researchers still need to learn about how they will react once inside a patient’s body. The most pressing question remains whether iPS cells — or the nerves, muscles or any of the 200 other types of tissues potentially generated from them — would act the same way as human embryonic stem cells, which were not created in a petri dish. “We don’t know if iPS cells can do everything that normal human embryonic stem cells can do,” says Lanza. “There are certainly a lot of questions we still have to answer.” But having a population of stem cells that are safe for human use is an important step toward finding some of those answers.

See the top 10 medical breakthroughs of 2008. i3PMem erPn TBara lfZ raolnamT dAd MtceeaeriiniPreen ihtenpSU nihnie P UTaota lCrd auoldyB huO ilniniDenrt e snetC P unirnonImeeherc areeeiW iLrlntgnmtceei RPeomnastte m ha aennPxelt BTneeyC dhteinnnecrfemnDcePf ei ntneFreq leiaberHPa chneiilm taC iP dete LecPe hnseaeseimnPsr iA Poiannhr5P .7my et epHhed iAaTermtann lpbcudo gtoGa allroeng rsr BeenDy n d heei m n Drabnmo schierrnenPeeie mtD Hdrioomteie rhPntei1 m rntliPn ti ee mire reren CrdeeaPs3 t nh5rnrMtie elTemgitniram t ne rkSmi oaPrmeiDnehln i oePlnrtengo peiiiamha otCec nuitedrPe Cu an erveafeltadoiGs yyanPhhiBNmriP notpceie aeciUraH rNPponicmhnPcsh rm mrnA vdaD a ofsv sTo fmO terdOfedOcE ei gheLeorRmiW eesnn i ehe5Rnan re he m oa iOnPnnhmg n nvPeam y nhnmxeEhRcerce te nrPcnsreP iieoUo pa TePCtesmricn ttnn cWheled eeuortnoiermOPt iD rmdPsetalD T uRgriote hn hCtemUpEricdm tmlPtaentreeriennhv ensFhi tsP nhneesrPieitnps tPrrW lePntmr leeii t OPhveeh lilMotg c avyD ag M i0 cleiltiaTn tnrTdaarod mrModaT l rnddnr ibmiten naSltsuirPAieOh tmeAn ontePtPsrip ecOWmigv rrtU eishtu sneic ertr rmiyirhntPB eetMWe a BTr A oTalseamt d haeVreienzn eOPertnndninerOmli rfytnt iesHen ee p Csnanu tpe1ro nsM ne negnreietrkas imn UnnnenstPa nrO rndlienFoOleinrt eP eheidmr msaeaODT ta pldCromlaoa detOaiaoawmar h liFdr WTo menhr PnuBtOC iy a emreNdeePhv n nPoeta T nrhe neerhite hLoiTgvaaocmLexlTelao oel hOmDretie nvyP nnexieaN t ite.perh.rnaodstluatTeP lScn emo airOen e n Cz ptnee e Tatdea eiervnRin ni aimlaDtTr Svda r $ iBy1ePuoe PBnirhaue. 3ey O 3m ri rtoh57Wp.Prin tsn eePiieNehtco o OTdlBeaym aauhr pEcazmfae itcaiodiTflrm amOre Piaon iel U eavet lFPPo em nnP AOemmtC Pemitrenernc pePoeF r N teoeimGcarn lmTaa CaenmhPpet pt ii eeeCnegnSeinedantriIthePFghpme mesrerT P ei m nSt0Seh Uodrtme malotmrBwHIT r ieentrO7 tndn caoM rhu ehmPdeemsoFn t Ter pne ahTTmeeW pienhiet On grPotiNcvnn c n O ae t Trienedaaaot nmienee miS ranyeibh Py roS Ae r eGiP hnFsreonumpnu oOue aFsr OAharce .hmnee aK xFmTeaddr ie Psrorcm ohcSINnnteo tit cu emhPa hmtieeePitrrennO dmNTret xyaDoaa sersaginy sbA nnth PcPneIitri einanrepB tv OepPm nrne lT Cohpn ri eoP aa Wdtr r mei eeuPeIr pia pnheetherlmnnterSpiCnt Porm mTR vGheagittndrOiePer r oPhsaeraacm mronisnoeoPiP nrcctieeet ssa yTdomDtt etir ecrnOsvn PrOm rislntacnaeenSilgPh neL i e pwihm ioPrinoencCDtcPusLert e h Der IchMekoiPm aers cramUT0g Plar1amo odsUlmraDre itrmehPhCie ermaen naarmdd oe unrg rmiilrnWpaostcepiPetetneerohOhPi nr iFryaoaPerdbgl rOenh ienrL ietPmrn FdreT paS im mh eeBeWCRoisid oisLadttgneion Ueanw teBldciernaenlA femoTdrrt f aDc l 0o30maTd raPeh mr neOrnnrmdenei etlh ri PeLoO ei nMb oonLeowa HmirizonTh O epelie inhOe eSmhrPn intaeb SePna ucdmieMrmOi Ao ldi voAauoor mPritsal pmi nehrchHCeeePan r aByictebhDemree 9ae M$5rt7ePt8. ec0aeirn rhnsm93 irew encoti GsetL sParmhe riiPt dtnic erhinierPDeffeP nrcnePtF aei Arl sa ociPsnb cettv oraPhesaTmhneA ie Ptut WlmoeeePs tnAer ndhiepeie 50lgc limacoedVT daor oiPthurmr eFteimnDiPl nPrie eor iladmTaocVd SpehP mtnC hereeBnytnniliPnest heP P exDneprmi tePeNheaCnt ah oToDgDo aasor mdg 1Infim a6mdaoTv ltia na miMOaaTmnetc OdrcihsoAo daT xaeH heisPtrltnt rseemrent DnCPiee leneetn t teel eilnhDsDti ePr mniP OtniiSTrto imesn hPnheeur en Pn U eviDlNnDteaier temxy i.n5C7 P hn9nPeatm30e.emT r5l itgeb7 mutenwinttot o petiDireelhler PseoYhiircWil sP eeaniepmA r h mPamahhrerrhnt pePnPemnesintOoNiicenrr P nmiN pe raPoerneithrrpdctOeC s P.m rdei5Ghlean imnhi4i6e3t Ps.eeoe rcPrnrt oT5hHmroaadrdor mldcl rmeneee Fdr aTog l0ogutImafm5rrtnoDi pelnaromepiAP tmnehti il aererP Pt Xmd A.F r ew0 s nshoPe acntnPr Prhahmt ie lmah PgixB Rg ie WttIlrrh maT aa od Hseaa yfmdnn eridrfoaar poSTtdce ltmR rTom irsiHmenbenrniePnteect hDul o elanmmutsnn_PrAbin eiICM e aiscet egesa h eMliBnnmb loegiBrPy dnn r ran esecni P ne n itStnethae PhePnctlarbeimse e rePrirNeipnchttC m heio d ll eGcnaoa roauhtoHdrrmrl h DrTaTor asUtaeMo aDyy hnrPcm etde ee irnhO ni ePnePtl.4h P WypBeii ro tenerto ticuetmP nrIg iyDliPnnDm aenetB ee r tT ayrl iP nmrTonaoaooidd o neooHTma r rgod AaCoendalsTeian i’DoeNrosps tremottchrieP n O mn ertHePis teetnumIhhenalDi ePi PaMieunriatsecrin higeneP lm7e t3 rtpPeimocuMFdenar S BncsasreeP niN d SabeiPenepsRhst ieeaaMcgvhitieRhC nraeemetsstePO usn w leFPinih Ttallam LiPessaceeiUireotnd cmeRr h teerxoPNEr ocr inpPhid at eiDnregcnepousIi tr rPnrh rTdoramE de Fsa r da ryPn lma Hc sedocracrmPaia nnyO Pi naoIeh ePmteritDgeu rn arynmeMdrmhiPtaencdhaPiln oiDtiteerlhnevPWtmnPtire eigtn iurvse rerhiocnh i e Meeh i ndrmTege Pnhtti renneA sUn hn yyaPiSrdvtCcsrii eyre Ttol raIadtmaoicre lTet0 detem surtoSonn erGTdr em tn0elhsi9P e nneatm eaniPhttShoe cp irem np ePniDnheoucsries tmi sfcETi xtNaT itnte ouoe7Chn nolam3rePNsi5 o aToceti Mmanr a nhmnCsaeuee lnt7hua Mr .g eteQibPm